biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".i just called to see how you guys are doing. give us a call � i hope you're having a good time, wherever you are..

on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation.